METHODS	Thirty-three patients with RA divided into 3 cohorts received TNFbp dimer ( 30 , 100 , 300 microg/kg ) or placebo during a 5 min infusion at baseline and at 3 and 6 weeks ; patients were followed at routine intervals after each infusion through 77 days postinfusion .\